Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
D000328:Adult; D000368:Aged; D000856:Anorexia Nervosa / Q000097:blood*; D001786:Blood Glucose / Q000378:metabolism; D002493:Central Nervous System Diseases / Q000097:blood*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009410:Nerve Degeneration; D010300:Parkinson Disease / Q000097:blood*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013997:Time Factors
D001786:Blood Glucose; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone; D011433:Propranolol; D005947:Glucose; D010646:Phentolamine